Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 3, Issue 5, pp. 455-463
PubMed
Published By
Print ISSN
Online ISSN
History
- Received November 9, 2014
- Revision received March 9, 2015
- Accepted March 12, 2015
- Published first March 19, 2015.
Article Versions
- Previous version (March 19, 2015 - 07:53).
- Previous version (April 15, 2015 - 14:12).
- You are viewing the most recent version of this article.
Copyright & Usage
©2015 American Association for Cancer Research.
Author Information
- Jashodeep Datta1*,
- Shuwen Xu1*,
- Cinthia Rosemblit1,
- Jenessa B. Smith2,
- Jessica A. Cintolo1,
- Daniel J. Powell Jr2, and
- Brian J. Czerniecki1,3,*
- 1Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
- 2Department of Pathology and Laboratory Medicine; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
- 3Rena Rowen Breast Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
- ↵*Corresponding Author:
Brian J. Czerniecki, University of Pennsylvania, 3400 Civic Center Drive, 3 Perelman Center, Philadelphia, PA 19104. Phone: 215-615-1696; Fax: 215-615-0555; E-mail: brian.czerniecki{at}uphs.upenn.edu
*J. Datta and S. Xu contributed equally to this article.
May 2015
Volume 3, Issue 5
Volume 3, Issue 5
CD4+ T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8+ T-cell Targeting of HER2/neu–Expressing Cancers
Jump to section
Advertisement